United States · FDA National Drug Code directory
Oxify
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 11383-002_4b0aaf61-d153-77de-e063-6294a90a2b9a
- Product NDC
- 11383-002
- Form
- CREAM
- Composition / generic term
- Lidocaine 5%
- Labeler
- Weeks & Leo Compnay, INC.
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start / end (source format)
- 20251031
- Source listing expiry
- 20271231
Source-listed ingredients
- LIDOCAINE — 50 mg/g
These values do not establish equivalence or a dose recommendation.
Packages
- 170 g in 1 JAR (11383-002-06) · 11383-002-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →